ZNF703 and neoplasm: Although miR-491-5p was also found to target JMJD2B and ZNF-703 to act as a tumor suppressor in breast cancer as mentioned previously [9,10,12], no investigations to pinpoint that RABIF is a direct target of miR-491-5p in breast cancer especially in TNBC in the past.